Cost-effectiveness of switching to insulin degludec from other basal insulins in real-world clinical practice in Italy.
Conclusions: Under routine care, switching to degludec is dominant, compared with continuing previous basal insulin, in Italian patients with T1D or T2D.
PMID: 31526202 [PubMed - as supplied by publisher]
Source: Journal of Medical Economics - Category: Health Management Tags: J Med Econ Source Type: research
More News: Diabetes | Diabetes Type 1 | Diabetes Type 2 | Economics | Endocrinology | Health Management | Healthcare Costs | Insulin | Italy Health | Study